Victoria Murcia-Gomez
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Upregulation of adenosine A2A receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficits.
Journal: Molecular psychiatry
Published: July 23, 2024
Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.
Journal: Brain : a journal of neurology
Published: November 30, 2023
Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model.
Journal: Frontiers in molecular neuroscience
Published: December 22, 2021
Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease.
Journal: Neuropharmacology
Published: December 16, 2021
Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects.
Journal: The Journal of clinical investigation
Published: July 06, 2021
Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription.
Journal: The Journal of clinical investigation
Published: March 08, 2021
IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease.
Journal: Cell reports
Published: August 27, 2020
Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy.
Journal: Neurobiology of aging
Published: April 01, 2020
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
Journal: Brain : a journal of neurology
Published: March 19, 2019
The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.
Journal: Frontiers in neuroscience
Published: April 16, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026